OSIR News and Press, Osiris Therapeutics Inc.

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Volatility watch: Some of the volatility names to watch include Nokia (NYSE: NOK ) , Kroger (NYSE: KR ) , Alexandria Real Estate (NYSE: ARE ) and Dave & Buster's Entertainment (NASDAQ: PLAY ) with short interest positions on the rise. Traders are also taking dead aim at retail n...

Quick Take ACell ( ACLL ) has filed to raise $75 million from the sale of its common stock, according to an amended registration statement . The company develops and sells wound treatment systems for various tissue care applications. ACLL was growing revenue sharply but has since felt t...

Quick Take ACell ( ACLL ) has filed to raise $86.25 million in an IPO of its common stock, according to an S-1 registration statement . The firm develops and sells various wound care products for post-surgical applications. ACLL has experienced a drop in sales as the Covid-19 pandemic ...

Editor's note: Seeking Alpha is proud to welcome FIN Capital Management LLC as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Essential. Click here to find out more » BAC...

Merger activity increased last week with five new deals announced and six pending deals closing. Deal Statistics: New Deals: The acquisition of Advanced Disposal Services (ADSW) by Waste Management (WM) for $4.9 billion or $33.15 per share in cash. The acquisition of Electro...

Investment Thesis While Osiris Therapeutics (OSIR) has appreciated 40% during the calendar year 2019, it is still significantly undervalued. The company's sales growth and earnings growth have been accelerating due to OSIR's increasing market success with its impactful suite of medical solut...

NEW YORK , March 27, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating the proposed merger of Osiris Therapeutics, Inc. ("OSIRIS" or the "Company") (NASDAQ:OSIR) with Smith & Nephew plc. Click here for more informati...

I have been studying what effect uplisting has on the stock price of individual stocks. My first article concluded that a profit exceeding 25% was available in 65% of stocks that had uplisted during 2015 but that profit evaporated within the first year after uplisting. Only 10% of these same...

I have been researching Osiris Therapeutics (NASDAQ: OSIR) for several years. Last year I began summarizing my perspective in articles on Seeking Alpha. My most recent blog post was September 2018. I did this to fill the void left by a lack of public analyst coverage. While I have been the...